GlassScriptPhysician profile
Michael Sean Dempsey
NPI 1962575597
$8,414.89
in general payments reported to CMS, 2019-2025
31 companies · $428 in 2025
The $428 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $579 · 2020: $127 · 2021: $538 · 2022: $5,724 · 2023: $786 · 2024: $232 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,348 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,348.20 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,117.53 | 2022-2024 | Da Vinci Surgical System |
| Abbvie INC. | $806.82 | 2019-2025 | Lo Loestrin Fe, Orilissa, Ubrelvy |
| Hologic Sales and Service, LLC | $407.62 | 2021-2025 | Novasure, Myosure Tissue Removal Device, Aptima |
| Asensus Surgical, INC. | $401.42 | 2019 | |
| Astellas Pharma US INC | $278.70 | 2023-2025 | Veozah |
| Pfizer INC. | $209.75 | 2022-2025 | |
| Biogen, INC. | $146.82 | 2025 | Zurzuvae |
| Caldera Medical, INC | $137.68 | 2023 | Desara |
| Sumitomo Pharma America, INC. | $133.01 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $119.49 | 2021-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $58.22 | 2022 | |
| Mayne Pharma Commercial LLC | $57.60 | 2021-2022 | |
| Organon LLC | $54.21 | 2024-2025 | Nexplanon |
| Coopersurgical, INC. | $54.00 | 2021-2023 | Paragard T 380a |
| Evofem Biosciences, INC. | $47.03 | 2021-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $43.16 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $41.73 | 2020-2021 | |
| Scynexis, INC. | $34.92 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $32.11 | 2025 | |
| Si-Bone, INC. | $28.87 | 2022 | |
| Exeltis, USA INC. | $27.91 | 2025 | Slynd |
| Avion Pharmaceuticals | $25.41 | 2020-2023 | Balcoltra |
| Genzyme Corporation | $24.10 | 2023 | |
| Medline Industries LP | $21.95 | 2022 | |
| Optumhealth Care Solutions, LLC | $19.03 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Minerva Surgical, INC | $17.61 | 2022 | |
| Conmed Corporation | $17.37 | 2022 | |
| Lupin INC. | $13.27 | 2020 | |
| Advanced Respiratory, INC | $12.93 | 2021 | |
| Molnlycke Health Care US, LLC | $12.85 | 2021 | |
| Myovant Sciences INC. | $11.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dempsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.